Cargando…

Unmet clinical needs and burden of disease in hidradenitis suppurativa: real‐world experience from EU5 and US

BACKGROUND: Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating skin disease characterized by painful deep lesions and associated with substantial disease burden. OBJECTIVES: The objective of this study was to describe physician‐ and patient‐reported clinical unmet needs from a re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingram, J.R., Bettoli, V., Espy, J.I., Kokolakis, G., Martorell, A., Villani, A.P., Wallinger, H., Coak, E., Kasparek, T., Muscianisi, E., Richardson, C., Kimball, A.B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Jeadv September Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545202/ https://www.ncbi.nlm.nih.gov/pubmed/35445469 http://dx.doi.org/10.1111/jdv.18163

Ejemplares similares

Biallelic KITLG variants lead to a distinct spectrum of hypomelanosis and sensorineural hearing loss
por: Vona, B., et al.
Publicado: (2022)

Skin lesions in neurofibromatosis type 2: diagnostic and prognostic significance of cutaneous (plexiform) schwannomas
por: Plana‐Pla, A., et al.
Publicado: (2022)

Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort
por: Assan, F., et al.
Publicado: (2022)

Gut dysbiosis in cutaneous T‐cell lymphoma is characterized by shifts in relative abundances of specific bacterial taxa and decreased diversity in more advanced disease
por: Hooper, M.J., et al.
Publicado: (2022)

Dermoscopy of cutaneous adnexal tumours: a systematic review of the literature
por: Lai, M., et al.
Publicado: (2022)

The humanistic burden of vitiligo: a systematic literature review of quality‐of‐life outcomes
por: Picardo, M., et al.
Publicado: (2022)

Assessing unmet needs in patients with hidradenitis suppurativa
por: Chadha, Simran A., et al.
Publicado: (2023)

An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life()()
por: Storer, M.A., et al.
Publicado: (2018)

A survey of dermatologist perspectives on disease management of patients with hidradenitis suppurativa
por: Shi, Vivian Y., et al.
Publicado: (2022)

TNF-α inhibitors in the treatment of hidradenitis suppurativa
por: Savage, Kevin T., et al.
Publicado: (2019)

HIDRAdisk: an innovative visual tool to assess the burden of hidradenitis suppurativa
por: Chiricozzi, A., et al.
Publicado: (2018)

Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities
por: Crowley, JJ, et al.
Publicado: (2014)

Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
por: Garg, Amit, et al.
Publicado: (2022)

Targeting Metabolic Syndrome in Hidradenitis Suppurativa by Phytochemicals as a Potential Complementary Therapeutic Strategy
por: Witte, Katrin, et al.
Publicado: (2023)

Patient perspectives on diagnosis and management of hidradenitis suppurativa: A web-based survey
por: Hsiao, Jennifer L., et al.
Publicado: (2022)

Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors
por: Pinter, Andreas, et al.
Publicado: (2020)

Response to: Remission of hidradenitis suppurativa after bariatric surgery
por: Golbari, Nicole Mona, et al.
Publicado: (2018)

Hidradenitis suppurativa and adalimumab in the COVID-19 era
por: Marzano, Angelo Valerio, et al.
Publicado: (2021)

Hidradenitis suppurativa in AIDS
por: Khambhati, Ravi, et al.
Publicado: (2010)

Hidradenitis suppurativa and intimacy
por: Jemec, G.
Publicado: (2018)

Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?
por: Fletcher, Joshua, et al.
Publicado: (2021)

HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo‐controlled portion of a phase 2 adalimumab study
por: Kimball, A.B., et al.
Publicado: (2015)

Vulvar cancer in hidradenitis suppurativa
por: Vergeldt, T.F.M., et al.
Publicado: (2022)

Postoperative Quality of Life in Patients with Hidradenitis Suppurativa Utilizing the Hidradenitis Suppurativa Burden of Disease Tool
por: Guart, Jiddu A, et al.
Publicado: (2021)

Retrospective cohort study of pregnancy outcomes in hidradenitis suppurativa
por: Lyon, A.B., et al.
Publicado: (2020)

Baseline patient‐reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice
por: Kimball, A.B., et al.
Publicado: (2020)

Treatment of hidradenitis suppurativa resolves associated hematologic abnormalities
por: Morss-Walton, Peyton C., et al.
Publicado: (2022)

Teledermatology in the management of hidradenitis suppurativa: Should we improve this service?
por: Ruggiero, Angelo, et al.
Publicado: (2022)

New treatments and new assessment instruments for Hidradenitis suppurativa
por: van Straalen, Kelsey R., et al.
Publicado: (2022)

Surgical Management of Hidradenitis Suppurativa
por: Menderes, Adnan, et al.
Publicado: (2010)

Hidradenitis Suppurativa: Inside and Out
por: Patil, Sharmila, et al.
Publicado: (2018)

Multimodal management of hidradenitis suppurativa
por: Jemec, Gregor B.E.
Publicado: (2020)

Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020)

Secondary prevention of hidradenitis suppurativa
por: Kurzen, Hjalmar, et al.
Publicado: (2019)

Facklamia hominis in hidradenitis suppurativa
por: Basal, Yasmeen, et al.
Publicado: (2021)

Management of Severe Hidradenitis Suppurativa
por: Katzman, Ju Hee, et al.
Publicado: (2021)

Surgical Treatment in Hidradenitis Suppurativa
por: Shukla, Ratnakar, et al.
Publicado: (2022)

Surgical management of hidradenitis suppurativa
por: Gierek, Marcin, et al.
Publicado: (2022)

Hydroxychloroquine for the treatment of hidradenitis suppurativa
por: Brant, Elena Gonzalez, et al.
Publicado: (2023)

Certolizumab to treat hidradenitis suppurativa
por: Shadid, Asem, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aqu8dk5q2cif9pn213df75didd